Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENASIDENIB Cause Chronic obstructive pulmonary disease? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Chronic obstructive pulmonary disease have been filed in association with ENASIDENIB (Idhifa). This represents 0.1% of all adverse event reports for ENASIDENIB.

5
Reports of Chronic obstructive pulmonary disease with ENASIDENIB
0.1%
of all ENASIDENIB reports
1
Deaths
4
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From ENASIDENIB?

Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ENASIDENIB Cause?

Death (650) Off label use (213) Fatigue (202) Nausea (197) Acute myeloid leukaemia (163) Hospitalisation (149) Diarrhoea (144) Decreased appetite (122) Platelet count decreased (113) Drug ineffective (108)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which ENASIDENIB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

ENASIDENIB vs ENBREL ENASIDENIB vs ENCORAFENIB ENASIDENIB vs ENDOXAN ENASIDENIB vs ENDOXAN BAXTER ENASIDENIB vs ENDOXAN INJ

Related Pages

ENASIDENIB Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease ENASIDENIB Demographics